中文 | English
Return
Total: 3 , 1/1
Show Home Prev Next End page: GO
Author:(Eiji NISHIO)

1.The feasibility of women in medicine and acupuncture

Eiji NISHIO

Journal of the Japan Society of Acupuncture and Moxibustion 2019;69(4):246-253

2.A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial

Kensuke HORI ; Shin NISHIO ; Kimio USHIJIMA ; Yuka KASAMATSU ; Eiji KONDO ; Kazuhiro TAKEHARA ; Kimihiko ITO

Journal of Gynecologic Oncology 2021;32(4):e64-

3.Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma:the JGOG 3018 Trial

Takashi MOTOHASHI ; Akira YABUNO ; Hiroshi MICHIMAE ; Tetsuro OHISHI ; Miwa NONAKA ; Masashi TAKANO ; Shin NISHIO ; Hiroyuki FUJIWARA ; Keiichi KEIICHI ; Eiji KONDO ; Toru SUGIYAMA ; Tsutomu TABATA

Journal of Gynecologic Oncology 2021;32(1):e9-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3 , 1/1 Show Home Prev Next End page: GO